|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
���������ۺ��� |
|
�Ŵ� |
|
HLA |
| ��������������� | |
|
������ |
|
������ |
| PubMed | |
|
Article by |
|
Article by |
�������������Ŵ������о���չ
������, ������
������ѧ������ɽҽԺƤ���� �Ϻ� 200040
����������Ҫ�ۼ��ڡ��ۡ���ֳ����Ƥ��������ϵͳ����֢�Լ���,�䲡��ͷ���������δ��ȷ�������������Ͷ����Ŵ�ѧ�����й�,�Ҹ�ĸ���������Ķ�ͯ��������Ҳ��ǰ���������������Ŵ�ѧ״�����䷢���������ϸ����ԭ���������ϸ����ԭ�����ϵ�Ľ�չ��
[2] Mizuki N, Ota M, Katsuyama Y, et al. HLA class I genotyping including HLA-B*51 allele typing in the Iranian patients with Behcet's disease. Tissue Antigens, 2001, 57:457-462.
[3] Yasuoka H, Okasaki Y, Kawakami Y, et al. Autoreactive CD8+ cytotoxic T lymphocytes to major histocompatibility complex class I chain-related gene A in patients with Behcet's disease. Arthritis Rheum, 2004, 50:3658-3662.
[4] Verity DH, Marr JE, Ohno S, et al. Behcet's disease, the Silk Road and HLA-B51:historical and geographical perspectives. Tissue Antigens, 1999, 54:213-220.
[5] Mizuki N, Ota M, Yabuki K, et al. Localization of the pathogenic gene of Behcet's disease by microsatellite analysis of three different populations. Invest Ophthalmol Vis Sci, 2000, 41:3702-3708.
[6] Gul A, Uyar FA, Inanc M, et al. A weak association of HLA-B*2702 with Behcet's disease. Genes Immun, 2002, 3:368-372.
[7] Ahmad T, Wallace GR, James T, et al. Mapping the HLA association in Behcet's disease:a role for tumor necrosis factor polymorphisms? Arthritis Rheum, 2003, 48:807-813.
[8] Verjans GM, van Hagen PM, van der Kooi A, et al. Vgamma9Vdelta2 T cells recovered from eyes of patients with Behcet's disease recognize non-peptide prenyl pyrophosphate antigens. J Neuroimmunol, 2002, 130:46-54.
[9] Bank I, Duvdevani M, Livneh A. Expansion of gammadelta T-cells in Behcet's disease:role of disease activity and microbial flora in oral ulcers. J Lab Clin Med, 2003, 141:33-40.
[10] Wallace GR, Verity DH, Delamaine LJ, et al. MIC-A allele profilesand HLA class I associations in Behcet's disease. Immunogenetics,1999, 49:613-617.
[11] Verity DH, Vaughan RW, Madanat W, et al. Factor V Leiden mutation is associated with ocular involvement in Behcet disease. Am J Ophthalmol, 1999, 128:352-356.
[12] Akpolat T, Yilmas E, Akpolat I, et al. Amyloidosis in Behcet's disease and familial Mediterranean fever. Rheumatology (Oxford), 2002, 41:592-593.
[13] Steinle A, Li P, Morris DL, et al. Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family. Immunogenetics, 2001, 53:279-287.
[14] Shimoyama Y, Takeno M, Kashiwakura J, et al. Reduced KIR expression is associated with NKT cell expansion in patients with Behcet's disease. Arthritis Rheum, 1998, 41:S252.
[15] Verity DH, Wallace GR, Seed PT, et al. Soluble adhesion molecules in Behcet's disease. Ocul Immunol Inflamm, 1998, 6:81-92.